Day clinic and inpatient psychotherapy of depression – a randomized controlled pilot study

Day clinic and inpatient psychotherapy of depression – a randomized controlled pilot study - DIP-D

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000550

Enrollment

Registered

2010-11-25

Start date

2011-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33 F34.1

Interventions

Group 1: Multimodal day clinic psychotherapy, combined as individual and group therapy Group 2: Multimodal inpatient psychotherapy, combined as individual and group therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Depressive Disorder (F32, F33, or F34.1) and place of residence within 80 km around Heidelberg

Exclusion criteria

Exclusion criteria: psychotic and bipolar disorder, currently manifest addictive disorder, Borderline Personality Disorder, Anorexia nervosa, Bulimia nervosa and Binge Eating Disorder with > 3 binges/day, planned treatment duration < 4 weeks

Design outcomes

Primary

Measure	Time frame
Primary Outcome of the study are depressive symptoms 3 months after termination of therapy. The primary outcome will be rated by trained observes with the Hamilton Ratings Scale of Depression (HAM-D).	—

Secondary

Measure	Time frame
Secondary outcome is the number and intensity of depressive symptoms from the patients' view. This is assessed at termination of therapy as well as 3 months after termination with the Beck Depression Inventory (BDI). An additional secondary outcome is the number and intensity of global psychological symptoms from the patients perspective. This is assessed at termination of therapy as well as 3 months after termination with the revised Symptom Checklist 90 (SCL-90-R).	—

Measure

Time frame

Secondary outcome is the number and intensity of depressive symptoms from the patients' view. This is assessed at termination of therapy as well as 3 months after termination with the Beck Depression Inventory (BDI). An additional secondary outcome is the number and intensity of global psychological symptoms from the patients perspective. This is assessed at termination of therapy as well as 3 months after termination with the revised Symptom Checklist 90 (SCL-90-R).

—

Countries

Germany

Contacts

Public ContactUlrike Dinger

Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg

ulrike.dinger@med.uni-heidelberg.de06221/565888

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026